PaxMedica (PXMD) Competitors $0.0002 0.00 (0.00%) As of 08/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PXMD vs. CMRA, GNCAQ, GNCA, ARDS, STAB, NMTR, AMPE, CALA, EFTR, and HSTOShould you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), 9 Meters Biopharma (NMTR), Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), eFFECTOR Therapeutics (EFTR), and Histogen (HSTO). These companies are all part of the "pharmaceutical products" industry. PaxMedica vs. Its Competitors Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Statera Biopharma 9 Meters Biopharma Ampio Pharmaceuticals Calithera Biosciences eFFECTOR Therapeutics Histogen PaxMedica (NASDAQ:PXMD) and Comera Life Sciences (NASDAQ:CMRA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability. Which has higher earnings & valuation, PXMD or CMRA? Comera Life Sciences has higher revenue and earnings than PaxMedica. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPaxMedicaN/AN/A-$18.29MN/AN/AComera Life Sciences$1.00M0.01-$18MN/AN/A Which has more risk & volatility, PXMD or CMRA? PaxMedica has a beta of -0.99, suggesting that its stock price is 199% less volatile than the S&P 500. Comparatively, Comera Life Sciences has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Is PXMD or CMRA more profitable? Comera Life Sciences' return on equity of 0.00% beat PaxMedica's return on equity.Company Net Margins Return on Equity Return on Assets PaxMedicaN/A -3,167.89% -560.35% Comera Life Sciences N/A N/A N/A Do insiders & institutionals hold more shares of PXMD or CMRA? 4.9% of PaxMedica shares are held by institutional investors. 1.0% of PaxMedica shares are held by company insiders. Comparatively, 8.9% of Comera Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media refer more to PXMD or CMRA? In the previous week, PaxMedica's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score. Company Overall Sentiment PaxMedica Neutral Comera Life Sciences Neutral SummaryComera Life Sciences beats PaxMedica on 6 of the 7 factors compared between the two stocks. Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PXMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart PXMD vs. The Competition Export to ExcelMetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2K$810.92M$5.69B$9.80BDividend YieldN/A4.84%4.59%4.07%P/E RatioN/A1.1930.6825.54Price / SalesN/A26.14464.67116.55Price / CashN/A19.5638.2159.48Price / Book0.006.588.996.13Net Income-$18.29M-$4.98M$3.25B$264.89M7 Day PerformanceN/A3.14%4.75%2.66%1 Month PerformanceN/A2.50%6.72%3.05%1 Year PerformanceN/A17.33%30.59%25.05% PaxMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXMDPaxMedicaN/A$0.00flatN/AN/A$2KN/A0.002CMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070ARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$5KN/A0.0030STABStatera BiopharmaN/A$0.00flatN/A-83.3%$5KN/A0.0020NMTR9 Meters BiopharmaN/A$0.00+∞N/AN/A$3KN/A0.0020Gap UpAMPEAmpio PharmaceuticalsN/A$0.00flatN/A+31.8%$3KN/A0.0020CALACalithera Biosciences0.6027 of 5 stars$0.00-66.7%N/A-92.0%$1KN/A0.0060Gap DownEFTReFFECTOR TherapeuticsN/A$0.00flatN/A-99.6%$1KN/A0.0010HSTOHistogenN/A$0.00flatN/A-99.9%$1K$19K0.0020 Related Companies and Tools Related Companies CMRA Alternatives GNCAQ Alternatives GNCA Alternatives ARDS Alternatives STAB Alternatives NMTR Alternatives AMPE Alternatives CALA Alternatives EFTR Alternatives HSTO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PXMD) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access